Bioethics

BIO is committed to the socially responsible use of biotechnology to save or improve lives, improve the quality and abundance of food, and protect our environment. Our board of directors has adopted a Statement of Ethical Principles, and we continue to refine a comprehensive vision of ways to ensure biotechnology is used for the betterment of humankind and not abused.

BIO opposes cloning to create a new human being (reproductive cloning) because it is unsafe and unethical. However, it is important to distinguish between that and other appropriate and important uses of the technology such as cloning specific human cells, genes and other tissues that do not and cannot lead to a human being (therapeutic cloning).

The public has a strong interest in protecting research and research participants. Federal policy must find the right balance in protecting participants while allowing critical research to continue.

Patient requests for access to drugs and biologics prior to their approval has long created a dilemma for biotechnology companies. This document provides "Points to Consider" for biotechnology companies confronting these issues.

Human organ transplantation is a relatively new field of medicine that is now facing a significant challenge.

Stem (iPS) cells are created by re-programming a differentiated cell into a pluripotent state.